Enhanced System for Reducing HPV Incidence and Prevalence

Publication ID: 24-11857675_0001_PTD

Published: October 28, 2025

Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Enhanced System for Reducing HPV Incidence and Prevalence,” Published Technical Disclosure No. 24-11857675_0001_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857675_0001_PTD

This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,675.

Summary of the Inventive Concept

The inventive concept provides an advanced system for reducing the incidence and prevalence of human papillomavirus (HPV) types 16 and 18 in women, offering improved protection against sexually transmitted infections and enhanced local immunity.

Background and Problem Solved

The original patent method for reducing HPV incidence and prevalence had limitations, including fixed surface area of the uterine cervical device, lack of real-time monitoring, and limited adaptability to individual cervical microbiomes. The new inventive concept addresses these limitations by introducing dynamically adjustable surface area, real-time monitoring, and personalized recommendations for maintaining a healthy microbiome.

Detailed Description of the Inventive Concept

The system comprises a uterine cervical device with a dynamically adjustable surface area between approximately 418 mm2 to approximately 524 mm2, a control unit for adjusting the surface area based on the user's cervical microbiome, and a data analytics module for tracking the user's microbiome profile and providing personalized recommendations. The device features a copper filament layer with a spiral coil configuration and a sensor for detecting changes in the cervical microbiome. The system can be used to apply a therapeutic dose of a copper-based antimicrobial agent to the uterine cervix, monitor the local immune response, and adjust the dosage and duration of treatment.

Novelty and Inventive Step

The new claims introduce the concept of dynamically adjustable surface area, real-time monitoring, and personalized recommendations, which are not present in the original patent. The combination of these features provides a novel and non-obvious solution for reducing HPV incidence and prevalence.

Alternative Embodiments and Variations

Alternative embodiments may include varying the material composition of the uterine cervical device, incorporating additional sensors for monitoring other health metrics, or integrating the system with existing healthcare infrastructure. Variations may include adapting the system for use in different patient populations or developing miniaturized versions for increased convenience.

Potential Commercial Applications and Market

The enhanced system has significant commercial potential in the healthcare industry, particularly in the areas of women's health, infectious disease prevention, and personalized medicine. The target market includes healthcare providers, pharmaceutical companies, and medical device manufacturers seeking to develop innovative solutions for reducing HPV incidence and prevalence.

CPC Classifications

Section	Class	Group
A	A61	A61K9/0039
A	A61	A61F6/144
A	A61	A61K33/34

Section 103 Obviousness Analysis (PHOSITA)

▼

Field of Art

Medical device technologies for reproductive health, specifically focused on uterine cervical interventions, antimicrobial treatments, and HPV prevention strategies. Requires expertise in medical device design, microbiology, immunology, and biomaterial engineering

Person of Ordinary Skill (PHOSITA) Profile

A medical device engineer or biomedical researcher with advanced degree, specialized knowledge in reproductive health technologies, familiar with copper-based medical interventions, microbiome monitoring techniques, and sexually transmitted infection prevention strategies

Obviousness Rationale

A person having ordinary skill would recognize that the source patent's copper-based uterine cervical device provides a foundational framework for technological enhancement. The PTD's variations represent predictable extensions of the original concept, utilizing known techniques in sensor integration, data analytics, and adaptive medical device design. These modifications would be considered routine optimization by a skilled practitioner seeking to improve HPV prevention technologies.

Obvious Combinations & Variations

Source Patent Element

Uterine cervical device with fixed copper surface area between 418-524 mm2

PTD Variation

Dynamically adjustable surface area with integrated control unit for microbiome-based modification

Obviousness Reasoning

Predictable design variation using known sensor and adaptive technology principles. A PHOSITA would recognize that adjustable medical devices represent a standard approach to personalized medical interventions

Source Patent Element

Method for reducing HPV incidence through copper-based device

PTD Variation

Adding data analytics module for tracking microbiome profile and providing personalized treatment recommendations

Obviousness Reasoning

Routine application of data monitoring technologies to medical device functionality. Integrating analytics represents a standard approach to precision medicine techniques

Source Patent Element

Copper-based uterine cervical device for HPV prevention

PTD Variation

Incorporating spiral coil configuration with embedded sensors for microbiome detection

Obviousness Reasoning

Known technique of enhancing medical device functionality through geometric modifications and sensor integration. A PHOSITA would find this a predictable engineering solution

Source Patent Element

Static device for HPV prevention

PTD Variation

Real-time monitoring system for adjusting therapeutic dosage and treatment duration

Obviousness Reasoning

Represents a standard approach to adaptive medical treatment, utilizing well-established principles of responsive medical technology

35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857675, the claimed variations in the present technical disclosure would be considered obvious to a person having ordinary skill in the art. The proposed modifications represent predictable technological extensions utilizing known techniques in medical device design, sensor integration, and personalized treatment strategies, thereby rendering subsequent claims involving similar technological approaches unpatentable under 35 U.S.C. Section 103.

Original Patent Information

Patent Number	US 11,857,675
Title	Method for reducing the incidence and prevalence of human papilloma virus (HPV) and for providing protection against sexually transmitted infections